FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Emerging Pandemics

COVID-19 vaccines safety update

04 Jun 2022

The safety of authorized COVID-19 vaccines is continuously monitored, and updated information is regularly provided to the public. Safety updates outline the outcomes from assessments of emerging worldwide safety data carried out mainly by EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) (section 1). They also outline how safety is monitored and contain high-level information on suspected adverse reaction reports, which PRAC takes into account in its assessments (section 2). This safety update follows the update of 17 February 2022 and reflects the main assessment outcomes of the PRAC meetings held 7 to 10 March 2022. EMA confirms that the benefits of all currently authorized COVID-19 vaccines continue to outweigh their side effects, given the risk of COVID-19 illness and related complications, including hospitalization and death.

Download PDF
PUBLISHED BY
European Medicines Agency
YEAR OF PUBLISHING
2022
AUTHORS
European Medicines Agency

Categories

COVID-19
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2022 Swasti Health Catalyst